0000000_iran

Europe sells Iran medicine, defying US sanctions

April 1, 2020
Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus

France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …

lilly_building_with_american_flag_web

Lilly partners with Sitryx in $880m immunometabolism drug development deal

April 1, 2020
Research and Development Eli Lilly, Sitryx, partnership, pharma

Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …

Axsome’s late-stage study of experimental depression drug misses main trial goal

March 31, 2020
Manufacturing and Production Depressive Disorder, MDD, depression, migraine

Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …

000_jjjj

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

March 31, 2020
Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020
Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …

000_parliiii

UK social distancing measures making a difference to the spread of COVID-19, government says

March 31, 2020
Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk

Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …

shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020
Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …

medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …

astrazeneca_building_white

FDA immunotherapy first with the approval of AZ’s Imfinzi in first-line extensive-stage small cell lung cancer

March 30, 2020
Sales and Marketing AstraZeneca, Cancer, FDA, Imfinzi, lung cancer, pharma

AstraZeneca has seized FDA approval for its immune checkpoint inhibitor Imfinzi (durvalumab) in the first-line treatment of extensive-stage small cell …

EMA gives market authorisation application to epilepsy treatment from Arvelle Therapeutics

March 30, 2020
Sales and Marketing EMA, EMA approvals, approvals, epilepsy

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for a cenobamate adjunctive treatment of focal-onset seizures …

hpv_vaccine

Sanofi agrees a second partnership to develop a COVID-19 vaccine

March 30, 2020
Sales and Marketing Vaccine, china coronavirus, coronavirus, coronavirus vaccine

Sanofi has partnered with Translate Bio to develop a novel messenger RNA (mRNA) vaccine for COVID-19 while they are also …

flag_of_world_health_organization_at_un_city

WHO launches “historic” multinational study to investigate most promising COVID-19 therapies

March 30, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir

The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …

000000_new_york

Hydroxychloroquine given to 1,100 patients with COVID-19 in New York

March 30, 2020
Sales and Marketing COVID-19, New York, china coronavirus, coronavirus

The malaria drug hydroxychloroquine is being administered to 1,100 patients in New York, which is fast becoming the new epicenter …

gary-jacob-cropped

Immunron Chief Executive Officer Gary Jacob resigns amidst coronavirus cost-cutting

March 27, 2020
Manufacturing and Production

The Chief Executive Officer of Immuron, Gary S. Jacob, has resigned as CEO and as a member of the Board …

mesa_biotech_accula

FDA invokes emergency powers to authorise 30-minute, handheld COVID-19 test

March 27, 2020
Medical Communications, Sales and Marketing COVID-19, FDA, Mesa Biotech, US, coronavirus

The FDA invoked Emergency Use Authorization powers to approve a rapid, handheld testing kit for COVID-19 coronavirus cases just days …

usa-4925212_640

US now leads world in COVID-19 cases as report warns it could face 80,000 deaths in four months

March 27, 2020
Medical Communications, Research and Development

The US now leads the world in total number of COVID-19 cases with more than 85,500 positives, ahead of China’s …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …

0000000000___30562517863_f4ff8e801a_b

British Prime Minister Boris Johnson tests positive for coronavirus

March 27, 2020
Medical Communications COVID-19, Coroanvirus

British Prime Minister Boris Johnson has tested positive for coronavirus, developing mild symptoms over the last 24 hours which included …

Teva donates millions of hydroxychloroquine sulfate tablets, touted by Trump as coronavirus treatment

March 27, 2020
Medical Communications Trump, coronavirus

Teva pharmaceuticals have said they will provide ten million doses of its anti-malaria drug hydroxychloroquine, which President Trump has been …

190509-f-jf989-032

COVID-19 may significantly hurt the drug supply chains of the biggest pharmaceutical companies

March 27, 2020
Medical Communications COVID-19, Coroanvirus, Wuhan Coronavirus, china coronavirus

The increasing spread of the COVID-19 coronavirus pandemic threatens the drug supply lines of the biggest pharmaceutical companies, including AstraZeneca, …

The Gateway to Local Adoption Series

Latest content